Completed Infection & Immunity Public Health & Healthcare

Centre for Infectious Diseases Research in Africa (CIDRI-Africa)

In plain English

AI plain-English summary

A new centre in Cape Town will embed cutting-edge research laboratories directly within one of the world’s highest-burden settings for HIV and tuberculosis, aiming to turn lab discoveries into better treatments faster. The problem is stark: the countries that need new drugs and vaccines for HIV and TB the most often lack the research infrastructure to develop them. Most clinical trials happen in wealthy nations, meaning treatments are tested on populations far removed from the people who will ultimately use them. CIDRI-Africa will close this gap by building shared platforms—a clinical trials unit for experimental medicine, expanded high-containment labs for handling live TB bacteria, and a data system that links patient records with lab results and population surveys. If successful, the centre will accelerate the testing of new TB drugs and HIV treatment strategies directly in the communities they are meant to serve. It will also tackle the growing overlap between infectious diseases and non-communicable conditions such as diabetes, which complicate treatment for millions on antiretroviral therapy. The work is translational, not fundamental science: its immediate goal is to shorten the path from a laboratory finding to a change in clinical practice.

View original technical description
We will create a centre for infectious diseases research in Africa (CIDRI-Africa) that conducts high-quality translational infectious disease research in a setting of tremendous disease burden. The juxtaposition of infection burden with sophisticated research laboratories offers unique advantage. We will foster investigator-led approaches via an overarching scientific theme: 1. To combat infection, especially HIV-1 and tuberculosis, via clinical and laboratory research Specific subthemes within this are: 2. To understand overlap between infections and non-communicable diseases of poverty, especially where the latter impact susceptibility to, or arise as a consequence of, infection 3. To understand and tackle the challenges (e.g. metabolic complications, resistance) of large-scale antiretroviral therapy. We will enable this by strengthening existing, and creating new, shared research platforms: 1. Developing the clinical research platform via increased integration with UCT’s Clinical Research Centre to grow phase II/III clinical trials scope with particular emphasis on Experimental Medicine. 2. Improving ability to bring cutting-edge analysis to infected materials by equipping and administering expanded tuberculosis Biosafety Level III facilities. 3. Enhancing ability to manage, integrate and analyse multidimensional population-based, clinical research, and laboratory data via a cross-cutting biomedical data integration platform.

View the original record at the funder ↗

Researchers

Robert Wilkinson (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Wellcome Centre for Infectious Diseases Research in Africa Discovery Platforms in Science
Establishment of a Centre for Clinical Infectious Diseases Research at the University of Cape Town (Wellcome-UCT-CCIDR).
Africa Health Research Institute (GBP record)
MRC Centre for Global Infectious Disease Analysis (MRC GIDA)
Makerere University UVRI Centre of Excellence for Infection & Immunity Research and Training (MUII-plus)

Original classification

Wellcome Trust Centre

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.